Global Piroxicam Capsules Market Growth 2026-2032
The global Piroxicam Capsules market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Piroxicam capsule is a nonsteroidal anti-inflammatory drug (NSAID) mainly used to relieve pain and inflammation caused by various factors. Its main ingredient is Piroxicam, a drug that selectively inhibits cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). It is commonly used to treat arthritis, osteoarthritis, rheumatoid arthritis and other conditions.
United States market for Piroxicam Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Piroxicam Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Piroxicam Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Piroxicam Capsules players cover SK Chemical, Pfizer, AdvaCare Pharma, Elikem Pharmaceuticals, DevLife, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Piroxicam Capsules Industry Forecast? looks at past sales and reviews total world Piroxicam Capsules sales in 2025, providing a comprehensive analysis by region and market sector of projected Piroxicam Capsules sales for 2026 through 2032. With Piroxicam Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Piroxicam Capsules industry.
This Insight Report provides a comprehensive analysis of the global Piroxicam Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Piroxicam Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Piroxicam Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Piroxicam Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Piroxicam Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Piroxicam Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Piroxicam Capsules market?
What factors are driving Piroxicam Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Piroxicam Capsules market opportunities vary by end market size?
How does Piroxicam Capsules break out by Type, by Application?
Piroxicam capsule is a nonsteroidal anti-inflammatory drug (NSAID) mainly used to relieve pain and inflammation caused by various factors. Its main ingredient is Piroxicam, a drug that selectively inhibits cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). It is commonly used to treat arthritis, osteoarthritis, rheumatoid arthritis and other conditions.
United States market for Piroxicam Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Piroxicam Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Piroxicam Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Piroxicam Capsules players cover SK Chemical, Pfizer, AdvaCare Pharma, Elikem Pharmaceuticals, DevLife, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Piroxicam Capsules Industry Forecast? looks at past sales and reviews total world Piroxicam Capsules sales in 2025, providing a comprehensive analysis by region and market sector of projected Piroxicam Capsules sales for 2026 through 2032. With Piroxicam Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Piroxicam Capsules industry.
This Insight Report provides a comprehensive analysis of the global Piroxicam Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Piroxicam Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Piroxicam Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Piroxicam Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Piroxicam Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Piroxicam Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Regular Release
- Modified Release
- Hospital
- Clinic
- Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- SK Chemical
- Pfizer
- AdvaCare Pharma
- Elikem Pharmaceuticals
- DevLife
- Nouvasant Group
- Teva Pharmaceuticals USA
- Baiyunshan
- Chongqing Kerui Pharmaceutical
- Guangdong Xinfeng Pharmaceutical
- Guangdong Zhongsheng Pharmaceutical
- Guangzhou Ouhua Pharmaceutica
- Guangdong Pidi Pharmaceutical
What is the 10-year outlook for the global Piroxicam Capsules market?
What factors are driving Piroxicam Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Piroxicam Capsules market opportunities vary by end market size?
How does Piroxicam Capsules break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Piroxicam Capsules Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Piroxicam Capsules by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Piroxicam Capsules by Country/Region, 2021, 2025 & 2032
2.2 Piroxicam Capsules Segment by Type
2.2.1 Regular Release
2.2.2 Modified Release
2.2.3 Piroxicam Capsules Sales by Type
2.2.3.1 Global Piroxicam Capsules Sales Market Share by Type (2021-2026)
2.2.3.2 Global Piroxicam Capsules Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Piroxicam Capsules Sale Price by Type (2021-2026)
2.3 Piroxicam Capsules Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Pharmacy
2.3.4 Piroxicam Capsules Sales by Application
2.3.4.1 Global Piroxicam Capsules Sale Market Share by Application (2021-2026)
2.3.4.2 Global Piroxicam Capsules Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Piroxicam Capsules Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Piroxicam Capsules Breakdown Data by Company
3.1.1 Global Piroxicam Capsules Annual Sales by Company (2021-2026)
3.1.2 Global Piroxicam Capsules Sales Market Share by Company (2021-2026)
3.2 Global Piroxicam Capsules Annual Revenue by Company (2021-2026)
3.2.1 Global Piroxicam Capsules Revenue by Company (2021-2026)
3.2.2 Global Piroxicam Capsules Revenue Market Share by Company (2021-2026)
3.3 Global Piroxicam Capsules Sale Price by Company
3.4 Key Manufacturers Piroxicam Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Piroxicam Capsules Product Location Distribution
3.4.2 Players Piroxicam Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PIROXICAM CAPSULES BY GEOGRAPHIC REGION
4.1 World Historic Piroxicam Capsules Market Size by Geographic Region (2021-2026)
4.1.1 Global Piroxicam Capsules Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Piroxicam Capsules Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Piroxicam Capsules Market Size by Country/Region (2021-2026)
4.2.1 Global Piroxicam Capsules Annual Sales by Country/Region (2021-2026)
4.2.2 Global Piroxicam Capsules Annual Revenue by Country/Region (2021-2026)
4.3 Americas Piroxicam Capsules Sales Growth
4.4 APAC Piroxicam Capsules Sales Growth
4.5 Europe Piroxicam Capsules Sales Growth
4.6 Middle East & Africa Piroxicam Capsules Sales Growth
5 AMERICAS
5.1 Americas Piroxicam Capsules Sales by Country
5.1.1 Americas Piroxicam Capsules Sales by Country (2021-2026)
5.1.2 Americas Piroxicam Capsules Revenue by Country (2021-2026)
5.2 Americas Piroxicam Capsules Sales by Type (2021-2026)
5.3 Americas Piroxicam Capsules Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Piroxicam Capsules Sales by Region
6.1.1 APAC Piroxicam Capsules Sales by Region (2021-2026)
6.1.2 APAC Piroxicam Capsules Revenue by Region (2021-2026)
6.2 APAC Piroxicam Capsules Sales by Type (2021-2026)
6.3 APAC Piroxicam Capsules Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Piroxicam Capsules by Country
7.1.1 Europe Piroxicam Capsules Sales by Country (2021-2026)
7.1.2 Europe Piroxicam Capsules Revenue by Country (2021-2026)
7.2 Europe Piroxicam Capsules Sales by Type (2021-2026)
7.3 Europe Piroxicam Capsules Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Piroxicam Capsules by Country
8.1.1 Middle East & Africa Piroxicam Capsules Sales by Country (2021-2026)
8.1.2 Middle East & Africa Piroxicam Capsules Revenue by Country (2021-2026)
8.2 Middle East & Africa Piroxicam Capsules Sales by Type (2021-2026)
8.3 Middle East & Africa Piroxicam Capsules Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Piroxicam Capsules
10.3 Manufacturing Process Analysis of Piroxicam Capsules
10.4 Industry Chain Structure of Piroxicam Capsules
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Piroxicam Capsules Distributors
11.3 Piroxicam Capsules Customer
12 WORLD FORECAST REVIEW FOR PIROXICAM CAPSULES BY GEOGRAPHIC REGION
12.1 Global Piroxicam Capsules Market Size Forecast by Region
12.1.1 Global Piroxicam Capsules Forecast by Region (2027-2032)
12.1.2 Global Piroxicam Capsules Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Piroxicam Capsules Forecast by Type (2027-2032)
12.7 Global Piroxicam Capsules Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 SK Chemical
13.1.1 SK Chemical Company Information
13.1.2 SK Chemical Piroxicam Capsules Product Portfolios and Specifications
13.1.3 SK Chemical Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 SK Chemical Main Business Overview
13.1.5 SK Chemical Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Piroxicam Capsules Product Portfolios and Specifications
13.2.3 Pfizer Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 AdvaCare Pharma
13.3.1 AdvaCare Pharma Company Information
13.3.2 AdvaCare Pharma Piroxicam Capsules Product Portfolios and Specifications
13.3.3 AdvaCare Pharma Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 AdvaCare Pharma Main Business Overview
13.3.5 AdvaCare Pharma Latest Developments
13.4 Elikem Pharmaceuticals
13.4.1 Elikem Pharmaceuticals Company Information
13.4.2 Elikem Pharmaceuticals Piroxicam Capsules Product Portfolios and Specifications
13.4.3 Elikem Pharmaceuticals Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Elikem Pharmaceuticals Main Business Overview
13.4.5 Elikem Pharmaceuticals Latest Developments
13.5 DevLife
13.5.1 DevLife Company Information
13.5.2 DevLife Piroxicam Capsules Product Portfolios and Specifications
13.5.3 DevLife Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 DevLife Main Business Overview
13.5.5 DevLife Latest Developments
13.6 Nouvasant Group
13.6.1 Nouvasant Group Company Information
13.6.2 Nouvasant Group Piroxicam Capsules Product Portfolios and Specifications
13.6.3 Nouvasant Group Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Nouvasant Group Main Business Overview
13.6.5 Nouvasant Group Latest Developments
13.7 Teva Pharmaceuticals USA
13.7.1 Teva Pharmaceuticals USA Company Information
13.7.2 Teva Pharmaceuticals USA Piroxicam Capsules Product Portfolios and Specifications
13.7.3 Teva Pharmaceuticals USA Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Teva Pharmaceuticals USA Main Business Overview
13.7.5 Teva Pharmaceuticals USA Latest Developments
13.8 Baiyunshan
13.8.1 Baiyunshan Company Information
13.8.2 Baiyunshan Piroxicam Capsules Product Portfolios and Specifications
13.8.3 Baiyunshan Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Baiyunshan Main Business Overview
13.8.5 Baiyunshan Latest Developments
13.9 Chongqing Kerui Pharmaceutical
13.9.1 Chongqing Kerui Pharmaceutical Company Information
13.9.2 Chongqing Kerui Pharmaceutical Piroxicam Capsules Product Portfolios and Specifications
13.9.3 Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Chongqing Kerui Pharmaceutical Main Business Overview
13.9.5 Chongqing Kerui Pharmaceutical Latest Developments
13.10 Guangdong Xinfeng Pharmaceutical
13.10.1 Guangdong Xinfeng Pharmaceutical Company Information
13.10.2 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product Portfolios and Specifications
13.10.3 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Guangdong Xinfeng Pharmaceutical Main Business Overview
13.10.5 Guangdong Xinfeng Pharmaceutical Latest Developments
13.11 Guangdong Zhongsheng Pharmaceutical
13.11.1 Guangdong Zhongsheng Pharmaceutical Company Information
13.11.2 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product Portfolios and Specifications
13.11.3 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Guangdong Zhongsheng Pharmaceutical Main Business Overview
13.11.5 Guangdong Zhongsheng Pharmaceutical Latest Developments
13.12 Guangzhou Ouhua Pharmaceutica
13.12.1 Guangzhou Ouhua Pharmaceutica Company Information
13.12.2 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product Portfolios and Specifications
13.12.3 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Guangzhou Ouhua Pharmaceutica Main Business Overview
13.12.5 Guangzhou Ouhua Pharmaceutica Latest Developments
13.13 Guangdong Pidi Pharmaceutical
13.13.1 Guangdong Pidi Pharmaceutical Company Information
13.13.2 Guangdong Pidi Pharmaceutical Piroxicam Capsules Product Portfolios and Specifications
13.13.3 Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Guangdong Pidi Pharmaceutical Main Business Overview
13.13.5 Guangdong Pidi Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Piroxicam Capsules Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Piroxicam Capsules by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Piroxicam Capsules by Country/Region, 2021, 2025 & 2032
2.2 Piroxicam Capsules Segment by Type
2.2.1 Regular Release
2.2.2 Modified Release
2.2.3 Piroxicam Capsules Sales by Type
2.2.3.1 Global Piroxicam Capsules Sales Market Share by Type (2021-2026)
2.2.3.2 Global Piroxicam Capsules Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Piroxicam Capsules Sale Price by Type (2021-2026)
2.3 Piroxicam Capsules Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Pharmacy
2.3.4 Piroxicam Capsules Sales by Application
2.3.4.1 Global Piroxicam Capsules Sale Market Share by Application (2021-2026)
2.3.4.2 Global Piroxicam Capsules Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Piroxicam Capsules Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Piroxicam Capsules Breakdown Data by Company
3.1.1 Global Piroxicam Capsules Annual Sales by Company (2021-2026)
3.1.2 Global Piroxicam Capsules Sales Market Share by Company (2021-2026)
3.2 Global Piroxicam Capsules Annual Revenue by Company (2021-2026)
3.2.1 Global Piroxicam Capsules Revenue by Company (2021-2026)
3.2.2 Global Piroxicam Capsules Revenue Market Share by Company (2021-2026)
3.3 Global Piroxicam Capsules Sale Price by Company
3.4 Key Manufacturers Piroxicam Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Piroxicam Capsules Product Location Distribution
3.4.2 Players Piroxicam Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PIROXICAM CAPSULES BY GEOGRAPHIC REGION
4.1 World Historic Piroxicam Capsules Market Size by Geographic Region (2021-2026)
4.1.1 Global Piroxicam Capsules Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Piroxicam Capsules Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Piroxicam Capsules Market Size by Country/Region (2021-2026)
4.2.1 Global Piroxicam Capsules Annual Sales by Country/Region (2021-2026)
4.2.2 Global Piroxicam Capsules Annual Revenue by Country/Region (2021-2026)
4.3 Americas Piroxicam Capsules Sales Growth
4.4 APAC Piroxicam Capsules Sales Growth
4.5 Europe Piroxicam Capsules Sales Growth
4.6 Middle East & Africa Piroxicam Capsules Sales Growth
5 AMERICAS
5.1 Americas Piroxicam Capsules Sales by Country
5.1.1 Americas Piroxicam Capsules Sales by Country (2021-2026)
5.1.2 Americas Piroxicam Capsules Revenue by Country (2021-2026)
5.2 Americas Piroxicam Capsules Sales by Type (2021-2026)
5.3 Americas Piroxicam Capsules Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Piroxicam Capsules Sales by Region
6.1.1 APAC Piroxicam Capsules Sales by Region (2021-2026)
6.1.2 APAC Piroxicam Capsules Revenue by Region (2021-2026)
6.2 APAC Piroxicam Capsules Sales by Type (2021-2026)
6.3 APAC Piroxicam Capsules Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Piroxicam Capsules by Country
7.1.1 Europe Piroxicam Capsules Sales by Country (2021-2026)
7.1.2 Europe Piroxicam Capsules Revenue by Country (2021-2026)
7.2 Europe Piroxicam Capsules Sales by Type (2021-2026)
7.3 Europe Piroxicam Capsules Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Piroxicam Capsules by Country
8.1.1 Middle East & Africa Piroxicam Capsules Sales by Country (2021-2026)
8.1.2 Middle East & Africa Piroxicam Capsules Revenue by Country (2021-2026)
8.2 Middle East & Africa Piroxicam Capsules Sales by Type (2021-2026)
8.3 Middle East & Africa Piroxicam Capsules Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Piroxicam Capsules
10.3 Manufacturing Process Analysis of Piroxicam Capsules
10.4 Industry Chain Structure of Piroxicam Capsules
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Piroxicam Capsules Distributors
11.3 Piroxicam Capsules Customer
12 WORLD FORECAST REVIEW FOR PIROXICAM CAPSULES BY GEOGRAPHIC REGION
12.1 Global Piroxicam Capsules Market Size Forecast by Region
12.1.1 Global Piroxicam Capsules Forecast by Region (2027-2032)
12.1.2 Global Piroxicam Capsules Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Piroxicam Capsules Forecast by Type (2027-2032)
12.7 Global Piroxicam Capsules Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 SK Chemical
13.1.1 SK Chemical Company Information
13.1.2 SK Chemical Piroxicam Capsules Product Portfolios and Specifications
13.1.3 SK Chemical Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 SK Chemical Main Business Overview
13.1.5 SK Chemical Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Piroxicam Capsules Product Portfolios and Specifications
13.2.3 Pfizer Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 AdvaCare Pharma
13.3.1 AdvaCare Pharma Company Information
13.3.2 AdvaCare Pharma Piroxicam Capsules Product Portfolios and Specifications
13.3.3 AdvaCare Pharma Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 AdvaCare Pharma Main Business Overview
13.3.5 AdvaCare Pharma Latest Developments
13.4 Elikem Pharmaceuticals
13.4.1 Elikem Pharmaceuticals Company Information
13.4.2 Elikem Pharmaceuticals Piroxicam Capsules Product Portfolios and Specifications
13.4.3 Elikem Pharmaceuticals Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Elikem Pharmaceuticals Main Business Overview
13.4.5 Elikem Pharmaceuticals Latest Developments
13.5 DevLife
13.5.1 DevLife Company Information
13.5.2 DevLife Piroxicam Capsules Product Portfolios and Specifications
13.5.3 DevLife Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 DevLife Main Business Overview
13.5.5 DevLife Latest Developments
13.6 Nouvasant Group
13.6.1 Nouvasant Group Company Information
13.6.2 Nouvasant Group Piroxicam Capsules Product Portfolios and Specifications
13.6.3 Nouvasant Group Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Nouvasant Group Main Business Overview
13.6.5 Nouvasant Group Latest Developments
13.7 Teva Pharmaceuticals USA
13.7.1 Teva Pharmaceuticals USA Company Information
13.7.2 Teva Pharmaceuticals USA Piroxicam Capsules Product Portfolios and Specifications
13.7.3 Teva Pharmaceuticals USA Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Teva Pharmaceuticals USA Main Business Overview
13.7.5 Teva Pharmaceuticals USA Latest Developments
13.8 Baiyunshan
13.8.1 Baiyunshan Company Information
13.8.2 Baiyunshan Piroxicam Capsules Product Portfolios and Specifications
13.8.3 Baiyunshan Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Baiyunshan Main Business Overview
13.8.5 Baiyunshan Latest Developments
13.9 Chongqing Kerui Pharmaceutical
13.9.1 Chongqing Kerui Pharmaceutical Company Information
13.9.2 Chongqing Kerui Pharmaceutical Piroxicam Capsules Product Portfolios and Specifications
13.9.3 Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Chongqing Kerui Pharmaceutical Main Business Overview
13.9.5 Chongqing Kerui Pharmaceutical Latest Developments
13.10 Guangdong Xinfeng Pharmaceutical
13.10.1 Guangdong Xinfeng Pharmaceutical Company Information
13.10.2 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product Portfolios and Specifications
13.10.3 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Guangdong Xinfeng Pharmaceutical Main Business Overview
13.10.5 Guangdong Xinfeng Pharmaceutical Latest Developments
13.11 Guangdong Zhongsheng Pharmaceutical
13.11.1 Guangdong Zhongsheng Pharmaceutical Company Information
13.11.2 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product Portfolios and Specifications
13.11.3 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Guangdong Zhongsheng Pharmaceutical Main Business Overview
13.11.5 Guangdong Zhongsheng Pharmaceutical Latest Developments
13.12 Guangzhou Ouhua Pharmaceutica
13.12.1 Guangzhou Ouhua Pharmaceutica Company Information
13.12.2 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product Portfolios and Specifications
13.12.3 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Guangzhou Ouhua Pharmaceutica Main Business Overview
13.12.5 Guangzhou Ouhua Pharmaceutica Latest Developments
13.13 Guangdong Pidi Pharmaceutical
13.13.1 Guangdong Pidi Pharmaceutical Company Information
13.13.2 Guangdong Pidi Pharmaceutical Piroxicam Capsules Product Portfolios and Specifications
13.13.3 Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Guangdong Pidi Pharmaceutical Main Business Overview
13.13.5 Guangdong Pidi Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Piroxicam Capsules Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Piroxicam Capsules Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Regular Release
Table 4. Major Players of Modified Release
Table 5. Global Piroxicam Capsules Sales by Type (2021-2026) & (K Units)
Table 6. Global Piroxicam Capsules Sales Market Share by Type (2021-2026)
Table 7. Global Piroxicam Capsules Revenue by Type (2021-2026) & ($ million)
Table 8. Global Piroxicam Capsules Revenue Market Share by Type (2021-2026)
Table 9. Global Piroxicam Capsules Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Piroxicam Capsules Sale by Application (2021-2026) & (K Units)
Table 11. Global Piroxicam Capsules Sale Market Share by Application (2021-2026)
Table 12. Global Piroxicam Capsules Revenue by Application (2021-2026) & ($ million)
Table 13. Global Piroxicam Capsules Revenue Market Share by Application (2021-2026)
Table 14. Global Piroxicam Capsules Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Piroxicam Capsules Sales by Company (2021-2026) & (K Units)
Table 16. Global Piroxicam Capsules Sales Market Share by Company (2021-2026)
Table 17. Global Piroxicam Capsules Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Piroxicam Capsules Revenue Market Share by Company (2021-2026)
Table 19. Global Piroxicam Capsules Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Piroxicam Capsules Producing Area Distribution and Sales Area
Table 21. Players Piroxicam Capsules Products Offered
Table 22. Piroxicam Capsules Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Piroxicam Capsules Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Piroxicam Capsules Sales Market Share Geographic Region (2021-2026)
Table 27. Global Piroxicam Capsules Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Piroxicam Capsules Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Piroxicam Capsules Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Piroxicam Capsules Sales Market Share by Country/Region (2021-2026)
Table 31. Global Piroxicam Capsules Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Piroxicam Capsules Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Piroxicam Capsules Sales by Country (2021-2026) & (K Units)
Table 34. Americas Piroxicam Capsules Sales Market Share by Country (2021-2026)
Table 35. Americas Piroxicam Capsules Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Piroxicam Capsules Sales by Type (2021-2026) & (K Units)
Table 37. Americas Piroxicam Capsules Sales by Application (2021-2026) & (K Units)
Table 38. APAC Piroxicam Capsules Sales by Region (2021-2026) & (K Units)
Table 39. APAC Piroxicam Capsules Sales Market Share by Region (2021-2026)
Table 40. APAC Piroxicam Capsules Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Piroxicam Capsules Sales by Type (2021-2026) & (K Units)
Table 42. APAC Piroxicam Capsules Sales by Application (2021-2026) & (K Units)
Table 43. Europe Piroxicam Capsules Sales by Country (2021-2026) & (K Units)
Table 44. Europe Piroxicam Capsules Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Piroxicam Capsules Sales by Type (2021-2026) & (K Units)
Table 46. Europe Piroxicam Capsules Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Piroxicam Capsules Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Piroxicam Capsules Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Piroxicam Capsules Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Piroxicam Capsules Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Piroxicam Capsules
Table 52. Key Market Challenges & Risks of Piroxicam Capsules
Table 53. Key Industry Trends of Piroxicam Capsules
Table 54. Piroxicam Capsules Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Piroxicam Capsules Distributors List
Table 57. Piroxicam Capsules Customer List
Table 58. Global Piroxicam Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Piroxicam Capsules Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Piroxicam Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Piroxicam Capsules Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Piroxicam Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Piroxicam Capsules Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Piroxicam Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Piroxicam Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Piroxicam Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Piroxicam Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Piroxicam Capsules Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Piroxicam Capsules Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Piroxicam Capsules Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Piroxicam Capsules Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. SK Chemical Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 73. SK Chemical Piroxicam Capsules Product Portfolios and Specifications
Table 74. SK Chemical Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. SK Chemical Main Business
Table 76. SK Chemical Latest Developments
Table 77. Pfizer Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Piroxicam Capsules Product Portfolios and Specifications
Table 79. Pfizer Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. AdvaCare Pharma Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 83. AdvaCare Pharma Piroxicam Capsules Product Portfolios and Specifications
Table 84. AdvaCare Pharma Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. AdvaCare Pharma Main Business
Table 86. AdvaCare Pharma Latest Developments
Table 87. Elikem Pharmaceuticals Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 88. Elikem Pharmaceuticals Piroxicam Capsules Product Portfolios and Specifications
Table 89. Elikem Pharmaceuticals Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Elikem Pharmaceuticals Main Business
Table 91. Elikem Pharmaceuticals Latest Developments
Table 92. DevLife Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 93. DevLife Piroxicam Capsules Product Portfolios and Specifications
Table 94. DevLife Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. DevLife Main Business
Table 96. DevLife Latest Developments
Table 97. Nouvasant Group Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 98. Nouvasant Group Piroxicam Capsules Product Portfolios and Specifications
Table 99. Nouvasant Group Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Nouvasant Group Main Business
Table 101. Nouvasant Group Latest Developments
Table 102. Teva Pharmaceuticals USA Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva Pharmaceuticals USA Piroxicam Capsules Product Portfolios and Specifications
Table 104. Teva Pharmaceuticals USA Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Teva Pharmaceuticals USA Main Business
Table 106. Teva Pharmaceuticals USA Latest Developments
Table 107. Baiyunshan Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 108. Baiyunshan Piroxicam Capsules Product Portfolios and Specifications
Table 109. Baiyunshan Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Baiyunshan Main Business
Table 111. Baiyunshan Latest Developments
Table 112. Chongqing Kerui Pharmaceutical Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 113. Chongqing Kerui Pharmaceutical Piroxicam Capsules Product Portfolios and Specifications
Table 114. Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Chongqing Kerui Pharmaceutical Main Business
Table 116. Chongqing Kerui Pharmaceutical Latest Developments
Table 117. Guangdong Xinfeng Pharmaceutical Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 118. Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product Portfolios and Specifications
Table 119. Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Guangdong Xinfeng Pharmaceutical Main Business
Table 121. Guangdong Xinfeng Pharmaceutical Latest Developments
Table 122. Guangdong Zhongsheng Pharmaceutical Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 123. Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product Portfolios and Specifications
Table 124. Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Guangdong Zhongsheng Pharmaceutical Main Business
Table 126. Guangdong Zhongsheng Pharmaceutical Latest Developments
Table 127. Guangzhou Ouhua Pharmaceutica Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 128. Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product Portfolios and Specifications
Table 129. Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Guangzhou Ouhua Pharmaceutica Main Business
Table 131. Guangzhou Ouhua Pharmaceutica Latest Developments
Table 132. Guangdong Pidi Pharmaceutical Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 133. Guangdong Pidi Pharmaceutical Piroxicam Capsules Product Portfolios and Specifications
Table 134. Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Guangdong Pidi Pharmaceutical Main Business
Table 136. Guangdong Pidi Pharmaceutical Latest Developments
Table 1. Piroxicam Capsules Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Piroxicam Capsules Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Regular Release
Table 4. Major Players of Modified Release
Table 5. Global Piroxicam Capsules Sales by Type (2021-2026) & (K Units)
Table 6. Global Piroxicam Capsules Sales Market Share by Type (2021-2026)
Table 7. Global Piroxicam Capsules Revenue by Type (2021-2026) & ($ million)
Table 8. Global Piroxicam Capsules Revenue Market Share by Type (2021-2026)
Table 9. Global Piroxicam Capsules Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Piroxicam Capsules Sale by Application (2021-2026) & (K Units)
Table 11. Global Piroxicam Capsules Sale Market Share by Application (2021-2026)
Table 12. Global Piroxicam Capsules Revenue by Application (2021-2026) & ($ million)
Table 13. Global Piroxicam Capsules Revenue Market Share by Application (2021-2026)
Table 14. Global Piroxicam Capsules Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Piroxicam Capsules Sales by Company (2021-2026) & (K Units)
Table 16. Global Piroxicam Capsules Sales Market Share by Company (2021-2026)
Table 17. Global Piroxicam Capsules Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Piroxicam Capsules Revenue Market Share by Company (2021-2026)
Table 19. Global Piroxicam Capsules Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Piroxicam Capsules Producing Area Distribution and Sales Area
Table 21. Players Piroxicam Capsules Products Offered
Table 22. Piroxicam Capsules Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Piroxicam Capsules Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Piroxicam Capsules Sales Market Share Geographic Region (2021-2026)
Table 27. Global Piroxicam Capsules Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Piroxicam Capsules Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Piroxicam Capsules Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Piroxicam Capsules Sales Market Share by Country/Region (2021-2026)
Table 31. Global Piroxicam Capsules Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Piroxicam Capsules Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Piroxicam Capsules Sales by Country (2021-2026) & (K Units)
Table 34. Americas Piroxicam Capsules Sales Market Share by Country (2021-2026)
Table 35. Americas Piroxicam Capsules Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Piroxicam Capsules Sales by Type (2021-2026) & (K Units)
Table 37. Americas Piroxicam Capsules Sales by Application (2021-2026) & (K Units)
Table 38. APAC Piroxicam Capsules Sales by Region (2021-2026) & (K Units)
Table 39. APAC Piroxicam Capsules Sales Market Share by Region (2021-2026)
Table 40. APAC Piroxicam Capsules Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Piroxicam Capsules Sales by Type (2021-2026) & (K Units)
Table 42. APAC Piroxicam Capsules Sales by Application (2021-2026) & (K Units)
Table 43. Europe Piroxicam Capsules Sales by Country (2021-2026) & (K Units)
Table 44. Europe Piroxicam Capsules Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Piroxicam Capsules Sales by Type (2021-2026) & (K Units)
Table 46. Europe Piroxicam Capsules Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Piroxicam Capsules Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Piroxicam Capsules Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Piroxicam Capsules Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Piroxicam Capsules Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Piroxicam Capsules
Table 52. Key Market Challenges & Risks of Piroxicam Capsules
Table 53. Key Industry Trends of Piroxicam Capsules
Table 54. Piroxicam Capsules Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Piroxicam Capsules Distributors List
Table 57. Piroxicam Capsules Customer List
Table 58. Global Piroxicam Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Piroxicam Capsules Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Piroxicam Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Piroxicam Capsules Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Piroxicam Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Piroxicam Capsules Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Piroxicam Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Piroxicam Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Piroxicam Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Piroxicam Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Piroxicam Capsules Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Piroxicam Capsules Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Piroxicam Capsules Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Piroxicam Capsules Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. SK Chemical Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 73. SK Chemical Piroxicam Capsules Product Portfolios and Specifications
Table 74. SK Chemical Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. SK Chemical Main Business
Table 76. SK Chemical Latest Developments
Table 77. Pfizer Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Piroxicam Capsules Product Portfolios and Specifications
Table 79. Pfizer Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. AdvaCare Pharma Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 83. AdvaCare Pharma Piroxicam Capsules Product Portfolios and Specifications
Table 84. AdvaCare Pharma Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. AdvaCare Pharma Main Business
Table 86. AdvaCare Pharma Latest Developments
Table 87. Elikem Pharmaceuticals Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 88. Elikem Pharmaceuticals Piroxicam Capsules Product Portfolios and Specifications
Table 89. Elikem Pharmaceuticals Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Elikem Pharmaceuticals Main Business
Table 91. Elikem Pharmaceuticals Latest Developments
Table 92. DevLife Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 93. DevLife Piroxicam Capsules Product Portfolios and Specifications
Table 94. DevLife Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. DevLife Main Business
Table 96. DevLife Latest Developments
Table 97. Nouvasant Group Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 98. Nouvasant Group Piroxicam Capsules Product Portfolios and Specifications
Table 99. Nouvasant Group Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Nouvasant Group Main Business
Table 101. Nouvasant Group Latest Developments
Table 102. Teva Pharmaceuticals USA Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva Pharmaceuticals USA Piroxicam Capsules Product Portfolios and Specifications
Table 104. Teva Pharmaceuticals USA Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Teva Pharmaceuticals USA Main Business
Table 106. Teva Pharmaceuticals USA Latest Developments
Table 107. Baiyunshan Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 108. Baiyunshan Piroxicam Capsules Product Portfolios and Specifications
Table 109. Baiyunshan Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Baiyunshan Main Business
Table 111. Baiyunshan Latest Developments
Table 112. Chongqing Kerui Pharmaceutical Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 113. Chongqing Kerui Pharmaceutical Piroxicam Capsules Product Portfolios and Specifications
Table 114. Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Chongqing Kerui Pharmaceutical Main Business
Table 116. Chongqing Kerui Pharmaceutical Latest Developments
Table 117. Guangdong Xinfeng Pharmaceutical Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 118. Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product Portfolios and Specifications
Table 119. Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Guangdong Xinfeng Pharmaceutical Main Business
Table 121. Guangdong Xinfeng Pharmaceutical Latest Developments
Table 122. Guangdong Zhongsheng Pharmaceutical Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 123. Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product Portfolios and Specifications
Table 124. Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Guangdong Zhongsheng Pharmaceutical Main Business
Table 126. Guangdong Zhongsheng Pharmaceutical Latest Developments
Table 127. Guangzhou Ouhua Pharmaceutica Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 128. Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product Portfolios and Specifications
Table 129. Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Guangzhou Ouhua Pharmaceutica Main Business
Table 131. Guangzhou Ouhua Pharmaceutica Latest Developments
Table 132. Guangdong Pidi Pharmaceutical Basic Information, Piroxicam Capsules Manufacturing Base, Sales Area and Its Competitors
Table 133. Guangdong Pidi Pharmaceutical Piroxicam Capsules Product Portfolios and Specifications
Table 134. Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Guangdong Pidi Pharmaceutical Main Business
Table 136. Guangdong Pidi Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Piroxicam Capsules
Figure 2. Piroxicam Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Piroxicam Capsules Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Piroxicam Capsules Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Piroxicam Capsules Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Piroxicam Capsules Sales Market Share by Country/Region (2025)
Figure 10. Piroxicam Capsules Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Regular Release
Figure 12. Product Picture of Modified Release
Figure 13. Global Piroxicam Capsules Sales Market Share by Type in 2026
Figure 14. Global Piroxicam Capsules Revenue Market Share by Type (2021-2026)
Figure 15. Piroxicam Capsules Consumed in Hospital
Figure 16. Global Piroxicam Capsules Market: Hospital (2021-2026) & (K Units)
Figure 17. Piroxicam Capsules Consumed in Clinic
Figure 18. Global Piroxicam Capsules Market: Clinic (2021-2026) & (K Units)
Figure 19. Piroxicam Capsules Consumed in Pharmacy
Figure 20. Global Piroxicam Capsules Market: Pharmacy (2021-2026) & (K Units)
Figure 21. Global Piroxicam Capsules Sale Market Share by Application (2025)
Figure 22. Global Piroxicam Capsules Revenue Market Share by Application in 2026
Figure 23. Piroxicam Capsules Sales by Company in 2026 (K Units)
Figure 24. Global Piroxicam Capsules Sales Market Share by Company in 2026
Figure 25. Piroxicam Capsules Revenue by Company in 2026 ($ millions)
Figure 26. Global Piroxicam Capsules Revenue Market Share by Company in 2026
Figure 27. Global Piroxicam Capsules Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Piroxicam Capsules Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Piroxicam Capsules Sales 2021-2026 (K Units)
Figure 30. Americas Piroxicam Capsules Revenue 2021-2026 ($ millions)
Figure 31. APAC Piroxicam Capsules Sales 2021-2026 (K Units)
Figure 32. APAC Piroxicam Capsules Revenue 2021-2026 ($ millions)
Figure 33. Europe Piroxicam Capsules Sales 2021-2026 (K Units)
Figure 34. Europe Piroxicam Capsules Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Piroxicam Capsules Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Piroxicam Capsules Revenue 2021-2026 ($ millions)
Figure 37. Americas Piroxicam Capsules Sales Market Share by Country in 2026
Figure 38. Americas Piroxicam Capsules Revenue Market Share by Country (2021-2026)
Figure 39. Americas Piroxicam Capsules Sales Market Share by Type (2021-2026)
Figure 40. Americas Piroxicam Capsules Sales Market Share by Application (2021-2026)
Figure 41. United States Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Piroxicam Capsules Sales Market Share by Region in 2026
Figure 46. APAC Piroxicam Capsules Revenue Market Share by Region (2021-2026)
Figure 47. APAC Piroxicam Capsules Sales Market Share by Type (2021-2026)
Figure 48. APAC Piroxicam Capsules Sales Market Share by Application (2021-2026)
Figure 49. China Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 53. India Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Piroxicam Capsules Sales Market Share by Country in 2026
Figure 57. Europe Piroxicam Capsules Revenue Market Share by Country (2021-2026)
Figure 58. Europe Piroxicam Capsules Sales Market Share by Type (2021-2026)
Figure 59. Europe Piroxicam Capsules Sales Market Share by Application (2021-2026)
Figure 60. Germany Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 61. France Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Piroxicam Capsules Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Piroxicam Capsules Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Piroxicam Capsules Sales Market Share by Application (2021-2026)
Figure 68. Egypt Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Piroxicam Capsules in 2026
Figure 74. Manufacturing Process Analysis of Piroxicam Capsules
Figure 75. Industry Chain Structure of Piroxicam Capsules
Figure 76. Channels of Distribution
Figure 77. Global Piroxicam Capsules Sales Market Forecast by Region (2027-2032)
Figure 78. Global Piroxicam Capsules Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Piroxicam Capsules Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Piroxicam Capsules Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Piroxicam Capsules Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Piroxicam Capsules Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Piroxicam Capsules
Figure 2. Piroxicam Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Piroxicam Capsules Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Piroxicam Capsules Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Piroxicam Capsules Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Piroxicam Capsules Sales Market Share by Country/Region (2025)
Figure 10. Piroxicam Capsules Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Regular Release
Figure 12. Product Picture of Modified Release
Figure 13. Global Piroxicam Capsules Sales Market Share by Type in 2026
Figure 14. Global Piroxicam Capsules Revenue Market Share by Type (2021-2026)
Figure 15. Piroxicam Capsules Consumed in Hospital
Figure 16. Global Piroxicam Capsules Market: Hospital (2021-2026) & (K Units)
Figure 17. Piroxicam Capsules Consumed in Clinic
Figure 18. Global Piroxicam Capsules Market: Clinic (2021-2026) & (K Units)
Figure 19. Piroxicam Capsules Consumed in Pharmacy
Figure 20. Global Piroxicam Capsules Market: Pharmacy (2021-2026) & (K Units)
Figure 21. Global Piroxicam Capsules Sale Market Share by Application (2025)
Figure 22. Global Piroxicam Capsules Revenue Market Share by Application in 2026
Figure 23. Piroxicam Capsules Sales by Company in 2026 (K Units)
Figure 24. Global Piroxicam Capsules Sales Market Share by Company in 2026
Figure 25. Piroxicam Capsules Revenue by Company in 2026 ($ millions)
Figure 26. Global Piroxicam Capsules Revenue Market Share by Company in 2026
Figure 27. Global Piroxicam Capsules Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Piroxicam Capsules Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Piroxicam Capsules Sales 2021-2026 (K Units)
Figure 30. Americas Piroxicam Capsules Revenue 2021-2026 ($ millions)
Figure 31. APAC Piroxicam Capsules Sales 2021-2026 (K Units)
Figure 32. APAC Piroxicam Capsules Revenue 2021-2026 ($ millions)
Figure 33. Europe Piroxicam Capsules Sales 2021-2026 (K Units)
Figure 34. Europe Piroxicam Capsules Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Piroxicam Capsules Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Piroxicam Capsules Revenue 2021-2026 ($ millions)
Figure 37. Americas Piroxicam Capsules Sales Market Share by Country in 2026
Figure 38. Americas Piroxicam Capsules Revenue Market Share by Country (2021-2026)
Figure 39. Americas Piroxicam Capsules Sales Market Share by Type (2021-2026)
Figure 40. Americas Piroxicam Capsules Sales Market Share by Application (2021-2026)
Figure 41. United States Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Piroxicam Capsules Sales Market Share by Region in 2026
Figure 46. APAC Piroxicam Capsules Revenue Market Share by Region (2021-2026)
Figure 47. APAC Piroxicam Capsules Sales Market Share by Type (2021-2026)
Figure 48. APAC Piroxicam Capsules Sales Market Share by Application (2021-2026)
Figure 49. China Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 53. India Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Piroxicam Capsules Sales Market Share by Country in 2026
Figure 57. Europe Piroxicam Capsules Revenue Market Share by Country (2021-2026)
Figure 58. Europe Piroxicam Capsules Sales Market Share by Type (2021-2026)
Figure 59. Europe Piroxicam Capsules Sales Market Share by Application (2021-2026)
Figure 60. Germany Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 61. France Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Piroxicam Capsules Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Piroxicam Capsules Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Piroxicam Capsules Sales Market Share by Application (2021-2026)
Figure 68. Egypt Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Piroxicam Capsules Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Piroxicam Capsules in 2026
Figure 74. Manufacturing Process Analysis of Piroxicam Capsules
Figure 75. Industry Chain Structure of Piroxicam Capsules
Figure 76. Channels of Distribution
Figure 77. Global Piroxicam Capsules Sales Market Forecast by Region (2027-2032)
Figure 78. Global Piroxicam Capsules Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Piroxicam Capsules Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Piroxicam Capsules Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Piroxicam Capsules Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Piroxicam Capsules Revenue Market Share Forecast by Application (2027-2032)
